Investigational Site Number : 2760005

Hamburg 20246

0 studies enrolling now · 2 studies all time

What they study most

Chronic Rhinosinusitis With Nasal Polyps, Metastatic Neoplasm

Studies at this site

• A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps — Running, not enrolling
• A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors — Stopped early